{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:15Z","timestamp":1792698075437,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08230-z","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:51:38Z","timestamp":1792651898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hip fracture risk in patients with Cushing\u2019s syndrome: a population-based cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8025","authenticated-orcid":false,"given":"Hiba","family":"Masri-Iraqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-8327","authenticated-orcid":false,"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5249","authenticated-orcid":false,"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0900-2923","authenticated-orcid":false,"given":"Keren","family":"Kaminer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-4759","authenticated-orcid":false,"given":"Idit","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tsvetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"8230_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/JAMA.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330:170\u2013181. https:\/\/doi.org\/10.1001\/JAMA.2023.11305.","journal-title":"JAMA"},{"key":"8230_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet 402:2237\u20132252. https:\/\/doi.org\/10.1016\/S0140-6736(23)01961-X","journal-title":"Lancet"},{"key":"8230_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diab Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diab Endocrinol"},{"key":"8230_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/S11102-015-0645-6","volume":"18","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA (2015) Comorbidities in Cushing\u2019s disease. Pituitary 18:188. https:\/\/doi.org\/10.1007\/S11102-015-0645-6","journal-title":"Pituitary"},{"key":"8230_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/CEN.12189","volume":"79","author":"M T\u00f5th","year":"2013","unstructured":"T\u00f5th M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 79:1\u201311. https:\/\/doi.org\/10.1111\/CEN.12189","journal-title":"Clin Endocrinol (Oxf)"},{"key":"8230_CR6","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1056\/NEJMCP1800214","volume":"379","author":"L Buckley","year":"2018","unstructured":"Buckley L, Humphrey MB (2018) Glucocorticoid-Induced Osteoporosis. N Engl J Med 379:2547\u20132556. https:\/\/doi.org\/10.1056\/NEJMCP1800214","journal-title":"N Engl J Med"},{"key":"8230_CR7","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S2213-8587(25)00251-7","volume":"13","author":"LC Hofbauer","year":"2025","unstructured":"Hofbauer LC, Compston JE, Saag KG et al (2025) Glucocorticoid-induced osteoporosis: novel concepts and clinical implications. Lancet Diab Endocrinol 13:964\u2013979. https:\/\/doi.org\/10.1016\/S2213-8587(25)00251-7","journal-title":"Lancet Diab Endocrinol"},{"key":"8230_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s11102-024-01391-2","volume":"27","author":"A Akirov","year":"2024","unstructured":"Akirov A, Rudman Y, Fleseriu M (2024) Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes. Pituitary 27:778\u2013788. https:\/\/doi.org\/10.1007\/s11102-024-01391-2","journal-title":"Pituitary"},{"key":"8230_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/S00198-025-07574-2","volume":"36","author":"SS Park","year":"2025","unstructured":"Park SS, Jeong H, Ahn CH et al (2025) Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study. Osteoporos Int 36:1951\u20131963. https:\/\/doi.org\/10.1007\/S00198-025-07574-2","journal-title":"Osteoporos Int"},{"key":"8230_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/S11102-024-01427-7","volume":"27","author":"A Zdrojowy-We\u0142na","year":"2024","unstructured":"Zdrojowy-We\u0142na A, Stachowska B, Bolanowski M (2024) Cushing\u2019s disease and bone. Pituitary 27:837\u2013846. https:\/\/doi.org\/10.1007\/S11102-024-01427-7","journal-title":"Pituitary"},{"key":"8230_CR11","doi-asserted-by":"publisher","first-page":"e13114","DOI":"10.1111\/JNE.13114","volume":"34","author":"E Valassi","year":"2022","unstructured":"Valassi E (2022) Clinical presentation and etiology of Cushing\u2019s syndrome: Data from ERCUSYN. J Neuroendocrinol 34:e13114. https:\/\/doi.org\/10.1111\/JNE.13114","journal-title":"J Neuroendocrinol"},{"key":"8230_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1210\/JC.2005-0582","volume":"91","author":"L Tauchmanov\u00e0","year":"2006","unstructured":"Tauchmanov\u00e0 L, Pivonello R, Di Somma C et al (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779\u20131784. https:\/\/doi.org\/10.1210\/JC.2005-0582","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/S00198-013-2520-5","volume":"25","author":"L Trementino","year":"2014","unstructured":"Trementino L, Appolloni G, Ceccoli L et al (2014) Bone complications in patients with Cushing\u2019s syndrome: looking for clinical, biochemical, and genetic determinants. Osteoporos Int 25:913\u2013921. https:\/\/doi.org\/10.1007\/S00198-013-2520-5","journal-title":"Osteoporos Int"},{"key":"8230_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/S00198-004-1740-0","volume":"16","author":"J Alegre-L\u00f3pez","year":"2005","unstructured":"Alegre-L\u00f3pez J, Cordero-Guevara J, Alonso-Valdivielso JL, Fern\u00e1ndez-Mel\u00f3n J (2005) Factors associated with mortality and functional disability after hip fracture: an inception cohort study. Osteoporos Int 16:729\u2013736. https:\/\/doi.org\/10.1007\/S00198-004-1740-0","journal-title":"Osteoporos Int"},{"key":"8230_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/S11102-024-01482-0","volume":"28","author":"Y Rudman","year":"2024","unstructured":"Rudman Y, Michaelis M, Shimon I et al (2024) Can we predict the risk of venous thromboembolism in patients with Cushing\u2019s syndrome: a nationwide cohort analysis. Pituitary 28:10. https:\/\/doi.org\/10.1007\/S11102-024-01482-0","journal-title":"Pituitary"},{"key":"8230_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/EJENDO\/LVAE098","volume":"191","author":"Y Rudman","year":"2024","unstructured":"Rudman Y, Fleseriu M, Dery L et al (2024) Endogenous Cushing\u2019s syndrome and cancer risk. Eur J Endocrinol 191:223\u2013231. https:\/\/doi.org\/10.1093\/EJENDO\/LVAE098","journal-title":"Eur J Endocrinol"},{"key":"8230_CR17","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1210\/JC.2007-0596","volume":"92","author":"FP Giraldi","year":"2007","unstructured":"Giraldi FP, Ambrogio AG, De Martin M et al (2007) Specificity of First-Line Tests for the Diagnosis of Cushing\u2019s Syndrome: Assessment in a Large Series. J Clin Endocrinol Metab 92:4123\u20134129. https:\/\/doi.org\/10.1210\/JC.2007-0596","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR18","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/JC.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526\u20131540. https:\/\/doi.org\/10.1210\/JC.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR19","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/JBMR.4033","volume":"35","author":"LT Braun","year":"2020","unstructured":"Braun LT, Fazel J, Zopp S et al (2020) The Effect of Biochemical Remission on Bone Metabolism in Cushing\u2019s Syndrome: A 2-Year Follow-Up Study. J Bone Min Res 35:1711\u20131717. https:\/\/doi.org\/10.1002\/JBMR.4033","journal-title":"J Bone Min Res"},{"key":"8230_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.eprac.2024.12.009","volume":"31","author":"N Charoenngam","year":"2025","unstructured":"Charoenngam N, Rittiphairoj T, Plessias C et al (2025) Bone mineral density improvement after resolution of endogenous Cushing syndrome: a systematic review and meta-analysis. Endocr Pract 31:345\u2013351. https:\/\/doi.org\/10.1016\/j.eprac.2024.12.009","journal-title":"Endocr Pract"},{"key":"8230_CR21","doi-asserted-by":"publisher","first-page":"bvaf008","DOI":"10.1210\/JENDSO\/BVAF008","volume":"9","author":"G Voltan","year":"2025","unstructured":"Voltan G, Mazzeo P, Cannito M et al (2025) Relationship among fragility fractures and the overall cardiovascular burden in endogenous Cushing syndrome. J Endocr Soc 9:bvaf008. https:\/\/doi.org\/10.1210\/JENDSO\/BVAF008","journal-title":"J Endocr Soc"},{"key":"8230_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/S00774-024-01502-W","volume":"42","author":"Y Tanaka","year":"2024","unstructured":"Tanaka Y, Soen S, Hirata S et al (2024) The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. J Bone Min Metab 42:143. https:\/\/doi.org\/10.1007\/S00774-024-01502-W","journal-title":"J Bone Min Metab"},{"key":"8230_CR23","doi-asserted-by":"publisher","first-page":"908727","DOI":"10.3389\/FENDO.2022.908727","volume":"13","author":"MR Laurent","year":"2022","unstructured":"Laurent MR, Goemaere S, Verroken C et al (2022) Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club. Front Endocrinol (Lausanne) 13:908727. https:\/\/doi.org\/10.3389\/FENDO.2022.908727","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8230_CR24","doi-asserted-by":"publisher","first-page":"2282183","DOI":"10.1080\/07853890.2023.2282183","volume":"55","author":"H Sun","year":"2023","unstructured":"Sun H, Wu C, Hu B, Xie G (2023) High prevalence of vertebral fractures associated with preoperative cortisol levels in patients with recent diagnosis of Cushing disease. Ann Med 55:2282183. https:\/\/doi.org\/10.1080\/07853890.2023.2282183","journal-title":"Ann Med"},{"key":"8230_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000489672","volume":"47","author":"SM Ott","year":"2018","unstructured":"Ott SM (2018) Cortical or trabecular bone: what\u2019s the difference?. Am J Nephrol 47:373\u2013375. https:\/\/doi.org\/10.1159\/000489672","journal-title":"Am J Nephrol"},{"key":"8230_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1350-4533(97)00030-1","volume":"19","author":"PHF Nicholson","year":"1997","unstructured":"Nicholson PHF, Cheng XG, Lowet G et al (1997) Structural and material mechanical properties of human vertebral cancellous bone. Med Eng Phys 19:729\u2013737. https:\/\/doi.org\/10.1016\/S1350-4533(97)00030-1","journal-title":"Med Eng Phys"},{"key":"8230_CR27","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/JC.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u0301o E, J\u00f8rgensen JOL et al (2013) Multisystem morbidity and mortality in cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab 98:2277\u20132284. https:\/\/doi.org\/10.1210\/JC.2012-3582","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR28","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1210\/CLINEM\/DGAA291","volume":"105","author":"E Papakokkinou","year":"2020","unstructured":"Papakokkinou E, Olsson DS, Chantzichristos D et al (2020) Excess Morbidity Persists in Patients with Cushing\u2019s Disease during Long-term Remission: A Swedish Nationwide Study. J Clin Endocrinol Metab 105:2616\u20132624. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA291","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1046\/J.1365-2265.2003.01713.X","volume":"58","author":"C Di Somma","year":"2003","unstructured":"Di Somma C, Pivonello R, Loche S et al (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study. Clin Endocrinol (Oxf) 58:302\u2013308. https:\/\/doi.org\/10.1046\/J.1365-2265.2003.01713.X","journal-title":"Clin Endocrinol (Oxf)"},{"key":"8230_CR30","doi-asserted-by":"publisher","unstructured":"Behary P, Raveendran D, Nair R, et al (2025) Clinical practice patterns in bone health assessment and management in endogenous Cushing\u2019s syndrome. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.70085","DOI":"10.1111\/cen.70085"},{"key":"8230_CR31","doi-asserted-by":"publisher","first-page":"dgz136","DOI":"10.1210\/CLINEM\/DGZ136","volume":"105","author":"G Rubinstein","year":"2020","unstructured":"Rubinstein G, Osswald A, Hoster E et al (2020) Time to Diagnosis in Cushing\u2019s Syndrome: A Meta-Analysis Based on 5367 Patients. J Clin Endocrinol Metab 105:dgz136. https:\/\/doi.org\/10.1210\/CLINEM\/DGZ136","journal-title":"J Clin Endocrinol Metab"},{"key":"8230_CR32","doi-asserted-by":"publisher","first-page":"117379","DOI":"10.1016\/j.bone.2024.117379","volume":"192","author":"K Wu","year":"2025","unstructured":"Wu K, Yan S, Wan J et al (2025) Hormones synthesized by the adrenal reticulum protect bone density in premenopausal women with Cushing syndrome. Bone 192:117379. https:\/\/doi.org\/10.1016\/j.bone.2024.117379","journal-title":"Bone"},{"key":"8230_CR33","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/JBMR.4028","volume":"35","author":"I Hurtado","year":"2020","unstructured":"Hurtado I, Garc\u00eda-Sempere A, Peir\u00f3 S et al (2020) Trends and geographical variability in osteoporosis treatment after hip fracture: a multilevel analysis of 30,965 patients in the region of Valencia, Spain. J Bone Min Res 35:1660\u20131667. https:\/\/doi.org\/10.1002\/JBMR.4028","journal-title":"J Bone Min Res"},{"key":"8230_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/S42836-024-00236-4","volume":"6","author":"M Yang","year":"2024","unstructured":"Yang M, Zhang Y (2024) Epidemiological features of 1,332 cases of hip fracture in Shanghai, China (2015-2020). Arthroplast (Lond, Engl) 6:18. https:\/\/doi.org\/10.1186\/S42836-024-00236-4","journal-title":"Arthroplast (Lond, Engl)"},{"key":"8230_CR35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1359\/JBMR.040134","volume":"19","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Min Res 19:893\u2013899. https:\/\/doi.org\/10.1359\/JBMR.040134","journal-title":"J Bone Min Res"},{"key":"8230_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11657-015-0244-1","volume":"10","author":"ZE Belaya","year":"2015","unstructured":"Belaya ZE, Hans D, Rozhinskaya LY et al (2015) The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing\u2019s syndrome. Arch Osteoporos 10:1\u20139. https:\/\/doi.org\/10.1007\/S11657-015-0244-1","journal-title":"Arch Osteoporos"},{"key":"8230_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1530\/EJE-21-0226","volume":"185","author":"P Van Houten","year":"2021","unstructured":"Van Houten P, Netea-Maier R, Wagenmakers M et al (2021) Persistent improvement of bone mineral density up to 20 years after treatment of Cushing\u2019s syndrome. Eur J Endocrinol 185:241\u2013250. https:\/\/doi.org\/10.1530\/EJE-21-0226","journal-title":"Eur J Endocrinol"},{"key":"8230_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/EJENDO\/LVAE069","volume":"191","author":"S Germann","year":"2024","unstructured":"Germann S, Wimmer R, Laager R et al (2024) Long-term outcomes in patients with Cushing\u2019s disease vs nonfunctioning pituitary adenoma after pituitary surgery: an active-comparator cohort study. Eur J Endocrinol 191:97\u2013105. https:\/\/doi.org\/10.1093\/EJENDO\/LVAE069","journal-title":"Eur J Endocrinol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08230-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:51Z","timestamp":1792695711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08230-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":38,"alternative-id":["8230"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08230-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MF has received research support to her institution from Crinetics and Sparrow and has received consulting fees from Crinetics, Lundbeck, Recordati, Sparrow, and Xeris. AA and IS are advisory board members for Medison, CTS Pharma, and Neopharm and have received scientific consulting fees from these companies. The remaining authors have no relevant financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}